Transfection of difficult-to-transfect primary mammalian cells

Methods in Molecular Biology

Volumn 801, Issue , 2012, Pages 65-74

  Gresch, Oliver ^a   Altrogge, Ludger ^a  

^a Lonza Cologne GmbH   (Germany)

Author keywords

HUVEC; Luciferase; Nucleofection; Primary cells; Transfection

Indexed keywords

GREEN FLUORESCENT PROTEIN; LUCIFERASE; TRYPSIN;

ARTICLE; CELL SURVIVAL; CULTURE TECHNIQUE; CYTOLOGY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; METHODOLOGY; STAINING; UMBILICAL VEIN ENDOTHELIAL CELL;

CELL CULTURE TECHNIQUES; CELL SURVIVAL; FLOW CYTOMETRY; GREEN FLUORESCENT PROTEINS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LUCIFERASES; MICROSCOPY, FLUORESCENCE; STAINING AND LABELING; TRANSFECTION; TRYPSIN;

MAMMALIA;

EID: 80555135885     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-352-3_5     Document Type: Article

References (29)

1. Athanasopoulos, T., Fabb, S., and Dickson, G. (2000) Gene therapy vectors based on adenoassociated virus: characteristics and applications to acquired and inherited diseases (review). Int J Mol Med 6, 363-375.
2. Sun, B., Zhang, H., Franco, L. M., Young, S. P., Schneider, A., Bird, A., et al. (2005) Efficacy of an adeno-associated virus 8-pseudotyped vector in glycogen storage disease type II. Molecular Therapy 11, 57-65. (Pubitemid 40011999)
3. Warrington, K. H., Jr., and Herzog, R. W. (2006) Treatment of human disease by adenoassociated viral gene transfer. Hum Genet 119, 571-603. (Pubitemid 43805835)
4. Bostick, B., Yue, Y., Lai, Y., Long, C., Li, D., and Duan, D. (2008) Adeno-associated virus serotype-9 microdystrophin gene therapy ameliorates electrocardiographic abnormalities in mdx mice. Hum Gene Ther 19, 851-856.
5. Yue, Y., Ghosh, A., Long, C., Bostick, B., Smith, B. F., Kornegay, J. N., et al. (2008) A single intravenous injection of adeno-associated virus serotype-9 leads to whole body skeletal muscle transduction in dogs. Molecular Therapy 16, 1944-1952.
6. Athanasopoulos, T., Graham, I. R., Foster, H., and Dickson, G. (2004) Recombinant adenoassociated viral (rAAV) vectors as therapeutic tools for Duchenne muscular dystrophy (DMD) (Review). Gene Ther 11 Suppl 1, S109-S121. (Pubitemid 39359455)
7. Sabatino, D. E., Mingozzi, F., Hui, D. J., Chen, H., Colosi, P., Ertl, H. C., et al. (2005) Identification of mouse AAV capsid-specific CD8+T cell epitopes. Molecular Therapy 12, 1023-1033. (Pubitemid 41723036)
8. Gao, G., Lu Y., Calcedo, R., Grant, R. L., Bell, P., Wang, L., et al. (2006) Biology of AAV serotype vectors in liver-directed gene transfer to nonhuman primates. Molecular Therapy 13, 77-87. (Pubitemid 41763485)
9. Manno C. S., Pierce G. F., Arruda V. R., Glader B., Ragni M., Rasko J. J., et al. (2006) Successful transduction of liver in hemophilia by AAVFactor IX and limitations imposed by the host immune response (erratum appears in Nat Med. 2006 May;12(5):592). Nat Med 12, 342-347. (Pubitemid 43355084)
10. Wang, Z., Allen, J. M., Riddell, S. R., Gregorevic, P., Storb, R., Tapscott, S. J., et al. (2007) Immunity to adeno-associated virusmediated gene transfer in a random-bred canine model of Duchenne muscular dystrophy. Hum Gene Ther 18, 18-26. (Pubitemid 46105461)
11. Brantly, M. L., Chulay, J. D., Wang, L., Mueller, C., Humphries, M., Spencer, L. T., et al. (2009) Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy (Erratum appears in Proc Natl Acad Sci USA. 2009 Oct 13;106(41):17606). Proc Natl Acad Sci USA 106, 16363-16368.
12. Halbert, C. L., Madtes, D. K., Vaughan, A. E., Wang, Z., Storb, R., Tapscott, S. J., et al. (2010) Expression of human α1-antitrypsin in mice and dogs following AAV6 vector-mediated gene transfer to the lungs. Molecular Therapy 18, 1165-1172.
13. Engers, H. D., Thomas, K., Cerottini, J. C., and Brunner, K. T. (1975) Generation of cytotoxic T lymphocytes in vitro. V. Response of normal and immune spleen cells to subcellular alloantigens. J Immunol 115, 356-360.
14. Altman, J. D., Moss, P. A., Goulder, P. J., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., et al. (1996) Phenotypic analysis of antigen-specific T lymphocytes Science 274, 94-96. (Pubitemid 26332731)
15. Appay, V., and Rowland-Jones, S. L. (2002) The assessment of antigen-specific CD8+T cells through the combination of MHC class I tetramer and intracellular staining (Review). J Immunol Methods 268, 9-19. (Pubitemid 35223103)
16. Murali-Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J., Zajac, A. J., Miller, J. D., et al. (1998) Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8, 177-187. (Pubitemid 28123745)
17. Kern F., Faulhaber, N., Frommel, C., Khatamzas, E., Prosch, S., Schonemann, C., et al. (2000) Analysis of CD8 T cell reactivity to cytomegalovirus using protein-spanning pools of overlapping pentadecapeptides. Eur J Immunol 30, 1676-1682. (Pubitemid 30342810)
18. Lalvani, A., Brookes, R., Hambleton, S., Britton, W. J., Hill, A. V., and McMichael, A. J. (1997) Rapid effector function in CD8+memory T cells. J Exp Med 186, 859-865. (Pubitemid 27407347)
19. Tobery, T. W., Wang, S., Wang, X. M., Neeper, M. P., Jansen, K. U., McClements, W. L., et al. (2001) A simple and efficient method for the monitoring of antigen-specific T cell responses using peptide pool arrays in a modified ELISpot assay. J Immunol Methods 254, 59-66. (Pubitemid 32530748)
20. Schmittel, A., Keilholz, U., and Scheibenbogen, C. (1997) Evaluation of the interferon-gamma ELISPOT-assay for quantification of peptide specific T lymphocytes from peripheral blood. J Immunol Methods 210, 167-174. (Pubitemid 28266560)
21. Kumar, A., Weiss, W., Tine, J. A., Hoffman, S. L., and Rogers, W. O. (2001) ELISPOT assay for detection of peptide specific interferongamma secreting cells in rhesus macaques. J Immunol Methods 247, 49-60. (Pubitemid 32057043)
22. Tobery, T. W., and Caulfield, M. J. (2004) Identification of T-cell epitopes using ELISpot and peptide pool arrays. Methods in Molecular Medicine 94, 121-132.
23. Maecker, H. T., Moon, J., Bhatia, S., Ghanekar, S. A., Maino, V. C., Payne, J. K., et al. (2005) Impact of cryopreservation on tetramer, cytokine flow cytometry, and ELISPOT. BMC Immunology 6, 17.
24. Smith, J. G., Joseph, H. R., Green, T., Field, J. A., Wooters, M., Kaufhold, R. M., et al. (2007) Establishing acceptance criteria for cell-mediated-immunity assays using frozen peripheral blood mononuclear cells stored under optimal and suboptimal conditions. Clinical and Vaccine Immunology 14, 527-537.
25. Arlen, P., Tsang, K. Y., Marshall, J. L., Chen, A., Steinberg, S. M., Poole, D., et al. (2000) The use of a rapid ELISPOT assay to analyze peptidespecific immune responses in carcinoma patients to peptide vs. recombinant poxvirus vaccines. Cancer Immunol Immunother 49, 517-529.
26. Kaufhold, R. M., Field, J. A., Caulfield, M. J., Wang, S., Joseph, H., Wooters M. A., et al. (2005) Memory T-cell response to rotavirus detected with a gamma interferon enzyme-linked immunospot assay. J Virol 79, 5684-5694. (Pubitemid 40548237)
27. Larsson, M., Jin, X., Ramratnam, B., Ogg, G. S., Engelmayer, J., Demoitie, M. A., et al. (1999) A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals. AIDS 13, 767-777. (Pubitemid 29224578)
28. Wang, R., Richie, T. L., Baraceros, M. F., Rahardjo, N., Gay, T., Banania, J. G., et al. (2005) Boosting of DNA vaccine-elicited gamma interferon responses in humans by exposure to malaria parasites. Infection & Immunity 73, 2863-2872. (Pubitemid 40570355)
29. Firbas, C., Jilma, B., Tauber, E., Buerger, V., Jelovcan, S., Lingnau, K., et al. (2006) Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: a randomized, placebo controlled trial for dose optimization in 128 healthy subjects. Vaccine 24, 4343-4353.